Search filters

List of works by Melissa Frizziero

A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status.

scientific article published on 6 November 2012

Carboplatin and gemcitabine in first-line treatment of elderly patients with advanced non-small cell lung cancer: data from a retrospective study

scientific article

Current Strategies to Overcome Resistance to ALK-Inhibitor Agents

scientific article published on 12 August 2015

Elderly patients diagnosed with hepatopancreatobiliary malignancies: A challenge beyond resection

scientific article published on 06 January 2017

Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis

scientific article published on 19 January 2020

Molecular analysis of a male breast cancer patient with prolonged stable disease under mTOR/PI3K inhibitors BEZ235/everolimus.

scientific article published on March 2016

Pancreatic cancer: systemic combination therapies for a heterogeneous disease.

scientific article

Second-line treatment in patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma: a systematic review and meta-analysis

scientific article published on 27 April 2020

Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma-a meta-analysis

scientific article published on 29 October 2018

TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients

scientific article

Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis

scientific article

Urgent need for consensus: international survey of clinical practice exploring use of platinum-etoposide chemotherapy for advanced extra-pulmonary high grade neuroendocrine carcinoma (EP-G3-NEC)

scientific article published on 30 November 2018